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Abstract
Background: Internet-based cognitive behavioral therapy can aid patients with rheumatoid arthritis with elevated levels of
distress to enhance their quality of life. However, implementation is currently lacking and there is little evidence available on the
(cost-) effectiveness of different treatment strategies.
Objective: Cost-benefit ratios are necessary for informing stakeholders and motivating them to implement effective treatment
strategies for improving health-related quality of life (HRQoL) of patients with rheumatoid arthritis. A cost-effectiveness study
from a societal perspective was conducted alongside a randomized controlled trial on a tailored, therapist-guided internet-based
cognitive behavioral therapy (ICBT) intervention for patients with rheumatoid arthritis with elevated levels of distress as an
addition to care as usual (CAU).
Methods: Data were collected at baseline or preintervention, 6 months or postintervention, and every 3 months thereafter during
the 1-year follow-up. Effects were measured in terms of quality-adjusted life years (QALYs) and costs from a societal perspective,
including health care sector costs (health care use, medication, and intervention costs), patient travel costs for health care use,
and costs associated with loss of labor.
Results: The intervention improved the quality of life compared with only CAU (Δ QALYs=0.059), but at a higher cost
(Δ=€4211). However, this increased cost substantially reduced when medication costs were left out of the equation (Δ=€1863).
Of all, 93% (930/1000) of the simulated incremental cost-effectiveness ratios were in the north-east quadrant, indicating a high
probability that the intervention was effective in improving HRQoL, but at a greater monetary cost for society compared with
only CAU.
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Conclusions: A tailored and guided ICBT intervention as an addition to CAU for patients with rheumatoid arthritis with elevated
levels of distress was effective in improving quality of life. Consequently, implementation of ICBT into standard health care for
patients with rheumatoid arthritis is recommended. However, further studies on cost reductions in this population are warranted.
Trial Registration: Nederlands Trial Register NTR2100; http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=2100
(Archived by WebCite at http://www.webcitation.org/724t9pvr2)
(J Med Internet Res 2018;20(10):e260)   doi:10.2196/jmir.9997
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Introduction
The psychological impact of rheumatoid arthritis has become
increasingly apparent, with patients reporting decreased
health-related quality of life (HRQoL) as a result of physical
factors, such as pain, and psychological factors, such as negative
mood [1-3]. As these factors are associated with the disease
trajectory, health care utilization, and workplace disability of
patients [4-8], they often lead to significant societal health
expenses [9-12].
Approximately one-third patients with rheumatoid arthritis
experience a significantly reduced HRQoL [1,3], and cognitive
behavioral therapy can aid in improving HRQoL [13-15]. In a
recent randomized controlled trial (RCT), we demonstrated that
a therapist-guided internet-based cognitive behavioral therapy
intervention (ICBT) that was tailored to specific problems of
individual patients with rheumatoid arthritis with elevated levels
of distress led to improvements in their psychological
functioning (eg, depressed mood) [16]. Findings of this study
were in agreement with those of previous studies on face-to-face
cognitive behavioral therapies [17], which our treatment protocol
closely resembled. Furthermore, it also supported previous
preliminary evidence suggesting that ICBT is as effective as
face-to-face treatments for a range of somatic conditions and
symptoms [18-20].
Several benefits of internet-based treatments, including increased
flexibility in terms of time and place, may make these treatments
feasible for widespread implementation [21,22]. Although
evidence on cost-effectiveness of internet-based therapy is still
scarce, preliminary results suggest that such interventions are
a cost-effective method to improve mental health, specifically
when guidance is provided by a psychological therapist [23].
One study examining a self-management intervention for
patients with RA reported a reduction in general distress and
pain, and improvement in self-efficacy, although no effects on
health care utilization were seen [24], which is important for
evaluation of costs. Furthermore, improved quality of life in
patients with chronic somatic conditions has previously been
associated with an improvement in medication adherence,
self-efficacy, and positive health outcomes [10,12]. This could
potentially reduce the cost of health care through, for example,
greater adherence to medications and increased employability
and work outcomes. However, the evidence on this is still scarce.
Specifically, no studies have examined the cost-effectiveness
of ICBT in patients with rheumatoid arthritis thus far. This
information is essential for allowing stakeholders to balance
treatment choices and policy decisions. For example, a recent
study summarized how rheumatologists balanced multiple
aspects of a treatment choice, including efficacy, patient
preferences, and costs [25].
This study describes a preplanned cost-effectiveness study
conducted from a societal perspective on the use of a tailored,
therapist-guided ICBT protocol as an addition to care as usual
(CAU) for patients with rheumatoid arthritis with elevated levels
of distress. This was conducted alongside RCT, the results of
which have been reported elsewhere [16]. We predicted that
ICBT would be a cost-effective intervention as addition to CAU.
In particular, costs that are relevant to society, that is, health
care sector costs such as medication costs, health care usage
costs, and work-related costs, were examined as these potentially
decrease with improving HRQoL.
Methods
Design
An economic evaluation of a tailored, therapist-guided ICBT
protocol as an addition to CAU was conducted from a societal
perspective alongside an RCT. Patients with elevated levels of
distress were randomly selected to receive standard
rheumatological care (as usually conducted in the Netherlands)
only or in combination with ICBT. Further details of the RCT
can be found in a previous study reporting the effects of ICBT
on the psychological functioning, physical functioning, and
impact of rheumatoid arthritis on daily life [16]. This study
focuses only on aspects relevant to economic evaluation. All
patients provided written informed consent for participation in
the study. The regional medical ethical committee approved the
study (NL24343.091.08), and it was registered with the
Nederlands Trial Register (NTR2100).
Participants
Adult patients with a rheumatologist-certified diagnosis of
rheumatoid arthritis [26] and receiving out-patient standard
rheumatological care at 1 academic and 3 nonacademic hospitals
were invited to participate in this study. Only patients with
elevated levels of distress, as defined by high scores for negative
mood (≥21 for negative mood on the Impact of Rheumatic
Diseases on General Health and Lifestyle scale) [27] and/or
anxiety (a score of ≥5 for anxiety on Impact of Rheumatic
Diseases on General Health and Lifestyle scale) were included.
The exclusion criteria were (1) insufficient command of the
Dutch language, (2) severe physical or psychiatric comorbidity
(ie, requiring acute or intensive medical attention; when this
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was not the case, patients indicated which condition impacted
their HRQoL to a greater extent), (3) pregnancy, (4) currently
receiving treatment from a cognitive behavioral therapist or
comparable practitioner, and (5) no access to a computer and
internet.
Care as Usual and Internet-Based Cognitive Behavioral
Intervention
CAU for patients with rheumatoid arthritis, which was provided
to the intervention and control groups, generally consists of
shared care checkups provided every 3-6 months by a
rheumatology nurse and the rheumatologist to monitor disease
activity and treatment. Hospitals in the Netherlands follow the
recommendations for rheumatological care provided by the
Dutch Society for Rheumatology. In addition, physical and
occupational therapy may be provided, depending on the patient
and disease characteristics.
The intervention group received ICBT as an addition to CAU.
The treatment was tailored to individual patient goals and
characteristics and guided by a therapist. The treatment
commenced with 1 or 2 face-to-face intake sessions comprising
formulation of individual goals based on the main problems of
the patient. Based on these goals, specific treatment modules
embedded within the ICBT website were selected, and the
therapist guided the choice of assignments within each of these
modules based on the specific risk and resilience factors of the
patient. Therapists and patients remained in contact weekly or
biweekly (based on patient preferences) via a secured messaging
service within the ICBT website. Treatment modules focused
on coping with (1) pain and functional disability, (2) fatigue,
(3) social functioning, and (4) negative mood. As the modules
were tailored to individual requirements, treatment durations
varied from 9 to 65 (mean 26.07, SD 12.22) weeks. All 6
therapists had a master’s degree in psychology and 2 had
additional postacademic training in cognitive behavioral therapy.
Supervision was provided by a senior clinical psychologist with
postacademic training in cognitive behavioral therapy. Patients
received 1 telephonic session that lasted for 30 minutes, where
a research assistant explained how the intervention website was
set up. Further information on the ICBT intervention can be
found in our previous study [16].
Data Collection and Outcome Measures
Data were collected at baseline; postintervention for the
intervention group and 6 months after baseline for the control
group; and at 3 (F1), 6 (F2), 9 (F3), and 12 months (F4)
thereafter. All questionnaires were filled out in paper and pencil
versions. All costs were calculated based on the 2015 Dutch
price indices. The last observation carried forward was applied
for missing data to account for biases introduced by
nonresponse.
Effects: Quality-Adjusted Life Years
HRQoL was assessed using the Dutch version of the
EuroQol-5dimensions-3levels (EQ-5D-3L) questionnaire [28].
EQ-5D-3L captures 5 dimensions of health, including mobility,
self-care, usual activities, pain or discomfort, and anxiety or
depression. Each dimension has 3 response options: no, some
or moderate, and extreme problems. Utility scores were
calculated using the Dutch tariff [28], with scores ranging from
0 (death) to 1 (perfect health). The trapezium rule was applied
for calculating area under the curve for measuring
quality-adjusted life years (QALYs).
Costs: Societal Perspective
Costs were calculated for 3 dimensions, including health care
sector costs (comprising health care use, medication, and costs
of the intervention under study), patient travel costs for health
care use, and costs associated with loss of labor (absenteeism
and presenteeism).
Health care use was assessed using the Trimbos or Institute for
Medical Technology Assessment questionnaire for Costs
associated with Psychiatric Illness (TiC-P) [29], which was
adjusted for health care use by patients with rheumatoid arthritis.
The questionnaire included patient appointments with
rheumatologists, specialized rheumatology nurses, occupational
therapists, physical therapists, podiatrists, and hydrotherapists;
admissions to daycare; and inpatient treatment at hospitals or
rehabilitation centers. Furthermore, TiC-P also assessed care
provided by a general practitioner and occupational health
doctor, psychological or psychosocial care (eg, care provided
by a psychologist, psychiatrist, or social worker), and care
provided by alternative medicine practitioners. Costs were
calculated by multiplying health care use with estimates of unit
prices, as provided by the TiC-P [29] and the Dutch manual for
cost analyses in health care [30].
All medications related to rheumatoid arthritis were taken into
account, including pain medication (eg, nonsteroidal
antiinflammatory drugs), corticosteroids, disease modifying
antirheumatic drugs, and biologics. Furthermore, medications
related to psychological symptoms, such as depression and
anxiety, as well as those related to sleep disorders were also
taken into consideration. Costs of these medications were
calculated by multiplying dosages for each type of medication
with their costs as per the Dutch national tariff list. The
medication history was self-reported by the patients.
In accordance with the Dutch guidelines for cost analyses in
health care [30], costs for the tailored, therapist-guided ICBT
protocol were calculated using (1) the actual costs of
development of the intervention by the ICT-company, which
included updating and security costs, (2) salary of the therapists
(as per rates for basic psychologists and those with a postdoc
training, where appropriate) based on the amount of time they
spent on treatment for each patient (including face-to-face intake
sessions, internet-based communication, and additional
telephone calls), (3) salary costs for the research assistant
conducting the telephone session to explain the intervention
website, and (4) patient traveling expenses for the face-to-face
intake sessions. An amortization period of 5 years was assumed.
Costs per patient were calculated based on prevalence rates of
rheumatoid arthritis provided by the Netherlands Institute for
Health Services Research [31]. An assumption was made that
30% of the rheumatoid arthritis population is eligible for this
intervention because of elevated levels of distress, as observed
in the RCT [16] and a previous trial targeting the same
population [17]. Of this population size, a population reach of
10% was assumed.
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Patient travel costs were calculated by multiplying the Dutch
standard for average travel distances from home to several health
care services (for example, hospital, general practitioner, and
physical therapist), as per the Dutch manual for cost analysis
in health care [30], with a price of €0.19 per kilometer.
Loss of productivity costs were calculated for 1 year using the
friction costs method including presenteeism and absenteeism,
based on self-reported data on loss of productivity collected via
the PROductivity and DIsease Questionnaire (PRODISQ) [32].
The friction period was calculated to a maximum of 12 weeks
[30]. An additional period of 4 weeks was taken into
consideration to allow management to fill the vacancy. Loss of
productivity costs was calculated by multiplying overall average
costs of productivity loss per hour (€34.90) [30] with the number
of hours that a patient was absent from work or was unable to
perform optimally at work because of rheumatoid arthritis.
Statistical Analysis
Differences in baseline sociodemographic (eg, age and gender),
disease-related (eg, disease severity), and economic (eg, paid
labor, health care costs, medication costs, and HRQoL)
characteristics between the intervention and control groups were
assessed using independent sample t tests or chi-square tests as
appropriate.
The costs per QALY gained were assessed using an incremental
cost-utility ratio (ICUR), calculated by dividing the difference
in costs by the difference in QALYs. Bootstrapping (1000
replications) was used to nonparametrically determine 95% CI.
Results of the bootstrap were presented and analyzed by means
of a cost-effectiveness plane and willingness-to-pay curve. The
Dutch Council for Public and Health Care (RVZ) recommends
that the threshold of the ICUR in relation to the acceptability
of the treatment has to depend on the severity of the disease
with a maximum ICUR of €80,000/QALY [33]. In accordance,
the probability that this intervention remains within this
threshold for willingness to pay is reported. As the intervention
was not primarily aimed at reducing medication costs and a
substantial proportion of patients with rheumatoid arthritis used
expensive biologic agents that strongly influenced cost
estimations, a secondary analysis was performed where costs
for medication were excluded.
Results
Patient Demographics
Patient demographics have been shown in Table 1 and Table 2.
This study included 133 patients, of which 62 patients were in
the ICBT group and 71 were in the CAU group. Measurements
at all time-points were provided by 27% (17/62) patients
allocated to the ICBT group and 42% (30/71) patients allocated
to the CAU group. No baseline differences in demographics,
disease-related characteristics, and cost- or effect-related
variables were observed. The patient sample, which included
more female than male patients (85 female and 48 male) and
had a mean age of 56.35 (SD 10.00; range: 26-81) years, was
a representative of patients with rheumatoid arthritis.
Between-Group Differences in Effects:
Quality-Adjusted Life Years
An overview of EQ-5D-3L utility scores for the intervention
and control groups has been shown in Table 3, based on a 1-year
follow-up period, indexed to the year 2015, for primary and
secondary analyses. Although HRQoL was found to be similar
for the intervention and control groups at baseline (P=.16), the
former exhibited a higher QALY score (mean QALY=0.86,
2.5-97.5 percentile=0.82-0.89) than the latter (mean
QALY=0.80, 2.5-97.5 percentile=0.76-0.83) during the 1-year
follow-up period.
Between-Group Differences in Costs: Societal
Perspective
The intervention and control groups did not exhibit any
differences with regard to all costs during the 1-year follow-up
period (Table 4), based on a 1-year follow-up period, indexed
to the year 2015. Total costs for the intervention amounted to
€419 per patient.
Table 1. Baseline patient characteristics: continuous variables.
CharacteristicsGroup
Disease activity (RADAIb)EQ-5D-3La
RangeMean (SD)RangeMean (SD)
0.40 to 7.273.84 (1.75)−0.11 to 1.00.69 (0.23)CAUc (N=71)
0.20 to 7.953.31 (1.99)0.09 to 1.00.74 (0.19)ICBTd + CAU (N=62)
0.20 to 7.953.59 (1.88)−0.11 to 1.00.71 (0.21)Total group (N=133)
aEQ-5D-3L: EuroQol-5dimensions-3 levels. Outcome analysis; group differences at baseline were analyzed using independent samples t tests as
appropriate. P=.16.
bRADAI: Rheumatoid Arthritis Disease Activity Index. Group differences at baseline were analysed using independent samples t tests as appropriate.
P=.11.
cCAU: care as usual.
dICBT: internet-based cognitive behavioral therapy.
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Table 2. Baseline patient characteristics: dichotomous variables.
P valuecTotal group (N=133)ICBTb + CAU (N=62)CAUa (N=71)Characteristics
MissingNoYesMissingNoYesMissingNoYes
.74562662303033236Medical comorbidity
.325121725823635Psychological comorbidity
.59473561332834028Employed
Medication use
.411310218646107568Painkillers
.641368526332373529NSAIDSd
.901322986104671252DMARDSe
.881395256441275113Corticoids
.261375456322474321Biologicals
.66131101065247586Mental Health Medication
aCAU: care as usual.
bICBT: internet-based cognitive behavioral therapy.
cOutcome analysis; group differences at baseline were analyzed using chi-square analysis or independent samples t tests as appropriate.
dNSAID: Nonsteroidal antiinflammatory drugs.
eDMARD: disease modifying antirheumatic drugs.
Table 3. Quality-adjusted life years and costs for the care as usual and internet-based cognitive behavioral therapy plus care as usual groups.
Δ CostsΔ QALYcICBTb + CAUCAUaAnalysis
CostsQALYCostsQALY
Primary analysis
€42110.059€15,7540.86€11,5420.80Average
−€6360.007€86710.82€11,8300.762.5 percentile
€94810.090€14,5990.89€20,1340.8397.5 percentile
Secondary analysis, excluding medication costs
€18630.0590€47740.86€28460.80Average
−€7140.007€25410.82€17430.762.5 percentile
€54280.090€77770.89€42430.8397.5 percentile
aCAU: care as usual.
bICBT: internet-based cognitive behavioral therapy.
cQALY: quality-adjusted life years.
Table 4. Mean costs for the care as usual and the internet-based cognitive behavioral therapy plus care as usual groups.
Difference between groups P valueICBTb + CAU, mean (SD)CAUa, mean (SD)Cost category
.52€3252 (8477)€2548 (3659)Health care use
.32€10,901 (13,257)€8682 (12,469)Medication use
.93€151 (160)€109 (135)Patient travel costs
.89€1309 (9106)€363 (1258)Absenteeism
.91€2239 (7133)€1800 (5853)Presenteeism
N/A€419N/AcICBT intervention
aCAU: care as usual.
bICBT: internet-based cognitive behavioral therapy.
cN/A: not applicable.
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Results of the cost-utility analysis have been presented in Table
3. Incremental effectiveness resulted in an effect of 0.059,
whereas incremental costs amounted to €4211.44 (2.5-97.5
percentile=−€636-9481). Therefore, the incremental cost-
effectiveness amounted to an investment of €71,424.82 costs
per QALY gained. The cost-effectiveness plane containing a
scatterplot of simulated ICURs has been shown in Figure 1.
Majority (93%, 930/1000) of simulated ICURs were in the
north-east quadrant, indicating a high probability that the
intervention was effective in improving HRQoL, but at a greater
cost for society compared with CAU. A total of 6% (60/1000)
of ICURs were in the south-east quadrant, suggesting greater
HRQoL effects at lower costs to society, and 1% (10/1000) of
ICURs were in the north-west quadrant, suggesting lower
HRQoL effects at higher costs to society (Figure 1). At a
willingness to pay of €80,000, the intervention had a 57% chance
of being cost-effective (Figure 2) for patients with rheumatoid
arthritis with elevated levels of distress.
Upon repeating the analysis without taking the medication costs
into account, incremental costs were seen to reduce to €1862.72
(2.5-97.5 percentile=−€714-€5428). The scatterplot of the
simulated ICURs remained approximately the same (Figure 3),
excluding costs of medication; however, the cost-effectiveness
acceptability curve exhibited an 87% chance of being
cost-effective at a willingness to pay of €80,000 (Figure 4) for
patients with rheumatoid arthritis with elevated levels of distress,
without taking medication costs into account.
Figure 1. The cost-effectiveness plane of simulated incremental cost-effectiveness ratios of internet-based cognitive behavioral therapy as an addition
to care as usual.
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Figure 2. Cost-effectiveness acceptability curve comparing internet-based cognitive behavioral therapy plus care as usual group to care as usual alone
group. ICUR: incremental cost-utility ratio; QALY: quality-adjusted life year.
Figure 3. Secondary analysis excluding medication costs: Cost-effectiveness plane of simulated incremental cost-effectiveness ratios of internet-based
cognitive behavioral therapy as an addition to care as usual.
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Figure 4. Secondary analysis excluding medication costs: Cost-effectiveness acceptability curve comparing the internet-based cognitive behavioral
therapy plus care as usual group to care as usual alone group.
Discussion
This study was conducted with the aim of gaining insight into
costs and effects of a tailored, therapist-guided ICBT protocol
as an addition to CAU for patients with rheumatoid arthritis and
elevated levels of distress. The key findings were (1) a positive
effect on QALYs was observed in the intervention group
compared with that in the control group; (2) cost ratios showed
that this effect came at a greater cost to society; and (3)
substantial costs in this population were generated by
medications, and there were no group differences with regard
to this. The cost-benefit ratio improved when costs of the
medications were excluded. Based on effects of the intervention
on improving the quality of life, implementation of the
intervention is recommended; however, with respect to its effect
on the costs, further study is warranted.
Results of this study are in agreement with those of previous
studies that reported promising results with regard to the
cost-effectiveness of therapist-guided psychological
interventions [22,23]. Guidance by a therapist comes at a cost,
which accumulates with the duration of treatment. Reducing
therapist time by, for example, using more automated or
prewritten responses could be beneficial in terms of costs, but
comes with the possible risk of losing tailored aspects of the
intervention. Future research should compare the
cost-effectiveness of a guided, partially-guided, or nonguided
intervention to identify the optimal amount of guidance
necessary for obtaining cost-effective results. Total costs of the
intervention per patient were very low in comparison to the
other costs accounted for, which makes the intervention a
relatively cheap addition to standard care for patients who might
benefit from this intervention in terms of their HRQoL.
Medication costs within the field of rheumatoid arthritis have
received considerable attention as biologics have a relatively
high cost, and a similar finding was observed in this study.
Although in the past there have been some indications that
improved psychological functioning increases medication
adherence and lowers medication use in the long term [12], no
group differences in medication costs were observed in this
study. Exclusion of medication costs from the analysis showed
a more beneficial cost-effectiveness ratio of the ICBT
intervention. Although adherence to medication was not an
explicit goal of this intervention, it would be worthwhile to
examine the ability of internet-based interventions in changing
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medication adherence patterns and medication use in patients
with rheumatoid arthritis [34]. These interventions could include,
for example, motivational interviews aimed at adherence [35].
Additional societal gains could also be attained by finding ways
to enable patients in actively participating in the workforce
[36,37].
The results of this study should be interpreted with caution
because of the presence of missing data, because not all patients
filled out all required measurements for the economic evaluation.
Although the last observation carried forward method was
applied for missing values, missing values can potentially lead
to biases in results.
In conclusion, the tailored, therapist-guided ICBT intervention
in patients with rheumatoid arthritis with elevated levels of
distress rendered higher effects on HRQoL with higher costs.
However, society may be willing to pay for the intervention as
these costs remain within the threshold generally stated for
health care interventions in the Netherlands. The findings of
this study were in support of implementation of the intervention
as a potential addition to CAU for patients with rheumatoid
arthritis with elevated levels of distress, although future studies
are necessary for optimizing the cost-benefit ratio.
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